1. Home
  2. PH vs BMY Comparison

PH vs BMY Comparison

Compare PH & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PH

Parker-Hannifin Corporation

HOLD

Current Price

$861.97

Market Cap

126.4B

Sector

Industrials

ML Signal

HOLD

Logo Bristol-Myers Squibb Company

BMY

Bristol-Myers Squibb Company

HOLD

Current Price

$60.03

Market Cap

123.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PH
BMY
Founded
1917
1887
Country
United States
United States
Employees
N/A
32500
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
126.4B
123.7B
IPO Year
2000
N/A

Fundamental Metrics

Financial Performance
Metric
PH
BMY
Price
$861.97
$60.03
Analyst Decision
Buy
Buy
Analyst Count
22
16
Target Price
$996.14
$61.81
AVG Volume (30 Days)
779.0K
9.7M
Earning Date
04-30-2026
04-30-2026
Dividend Yield
0.84%
4.22%
EPS Growth
24.18
N/A
EPS
12.89
N/A
Revenue
$14,302,392,000.00
N/A
Revenue This Year
$10.44
N/A
Revenue Next Year
$7.44
N/A
P/E Ratio
$66.81
$17.26
Revenue Growth
18.90
N/A
52 Week Low
$488.45
$42.52
52 Week High
$1,034.96
$62.89

Technical Indicators

Market Signals
Indicator
PH
BMY
Relative Strength Index (RSI) 32.88 53.90
Support Level $723.26 $59.23
Resistance Level $869.36 $62.47
Average True Range (ATR) 25.25 1.18
MACD -3.49 -0.07
Stochastic Oscillator 2.88 78.53

Price Performance

Historical Comparison
PH
BMY

About PH Parker-Hannifin Corporation

Parker Hannifin started out in 1917 as Parker Appliance, selling pneumatic brakes. Through the acquisition of branded components, the firm has expanded into aerospace engines, agricultural and construction machinery, freight and passenger vehicles, and industrial automation equipment. Within these larger systems, Parker sells a wide array of small, critical pieces such as hydraulic, electromechanical, climate control, and filtration components. Many of its products are designed to work together, resulting in a high rate of cross-selling.

About BMY Bristol-Myers Squibb Company

Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.

Share on Social Networks: